Opaleye Management as of Dec. 31, 2019
Portfolio Holdings for Opaleye Management
Opaleye Management holds 47 positions in its portfolio as reported in the December 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Epizyme | 6.7 | $34M | 1.4M | 24.60 | |
| Aptose Biosciences | 4.5 | $23M | 4.1M | 5.67 | |
| Codexis (CDXS) | 4.4 | $22M | 1.4M | 15.92 | |
| Forty Seven | 4.3 | $22M | 562k | 39.37 | |
| Stereotaxis (STXS) | 4.3 | $22M | 4.1M | 5.36 | |
| Turning Point Therapeutics I | 4.2 | $21M | 341k | 62.29 | |
| Ocular Therapeutix (OCUL) | 4.0 | $20M | 5.1M | 3.95 | |
| Imprimis Pharmaceuticals | 3.6 | $18M | 2.3M | 7.78 | |
| Eidos Therapeutics | 3.5 | $18M | 316k | 57.39 | |
| Audentes Therapeutics | 3.4 | $18M | 292k | 59.84 | |
| Neoleukin Therapeutics | 3.3 | $17M | 1.4M | 12.32 | |
| Uniqure Nv (QURE) | 3.0 | $15M | 210k | 71.66 | |
| Amarin Corporation | 2.8 | $14M | 665k | 21.44 | |
| Intra Cellular Therapies (ITCI) | 2.7 | $14M | 407k | 34.31 | |
| Deciphera Pharmaceuticals | 2.7 | $14M | 225k | 62.24 | |
| Chemocentryx | 2.7 | $14M | 362k | 38.29 | |
| Axogen (AXGN) | 2.5 | $13M | 700k | 17.89 | |
| Cerecor | 2.3 | $12M | 2.2M | 5.39 | |
| Odonate Therapeutics Ord | 2.3 | $12M | 355k | 32.45 | |
| Eton Pharmaceuticals (ETON) | 2.1 | $11M | 1.5M | 7.20 | |
| Xoma Corp Del (XOMA) | 2.0 | $10M | 374k | 27.30 | |
| Avenue Therapeutics | 1.9 | $9.9M | 1.0M | 9.60 | |
| Fortress Biotech | 1.9 | $9.8M | 3.8M | 2.57 | |
| Ptc Therapeutics I (PTCT) | 1.8 | $9.2M | 191k | 48.03 | |
| Biohaven Pharmaceutical Holding | 1.8 | $9.0M | 165k | 54.44 | |
| ACADIA Pharmaceuticals (ACAD) | 1.7 | $8.8M | 207k | 42.78 | |
| Flexion Therapeutics | 1.7 | $8.6M | 416k | 20.70 | |
| Blueprint Medicines (BPMC) | 1.6 | $8.0M | 100k | 80.01 | |
| Zymeworks | 1.6 | $8.0M | 175k | 45.46 | |
| Edap Tms (EDAP) | 1.6 | $7.9M | 1.8M | 4.43 | |
| Tricida | 1.4 | $7.3M | 194k | 37.64 | |
| Magenta Therapeutics | 1.3 | $6.7M | 450k | 14.95 | |
| Ra Pharmaceuticals | 1.3 | $6.7M | 142k | 46.93 | |
| Crinetics Pharmaceuticals In (CRNX) | 1.3 | $6.7M | 266k | 25.09 | |
| Tg Therapeutics (TGTX) | 1.3 | $6.4M | 580k | 11.10 | |
| Fibrogen | 1.2 | $6.3M | 146k | 42.89 | |
| Achillion Pharmaceuticals | 0.9 | $4.6M | 760k | 6.03 | |
| Kadmon Hldgs | 0.8 | $4.3M | 940k | 4.53 | |
| Aquestive Therapeutics (AQST) | 0.8 | $4.3M | 739k | 5.82 | |
| Radius Health | 0.7 | $3.4M | 168k | 20.16 | |
| Quanterix Ord (QTRX) | 0.6 | $3.1M | 132k | 23.63 | |
| Rhythm Pharmaceuticals (RYTM) | 0.5 | $2.5M | 111k | 22.96 | |
| Tela Bio (TELA) | 0.4 | $2.3M | 175k | 12.95 | |
| Macrogenics (MGNX) | 0.4 | $2.2M | 201k | 10.88 | |
| Fennec Pharmaceuticals (FENC) | 0.0 | $78k | 12k | 6.50 | |
| Biolinerx Ltd-spons | 0.0 | $38k | 17k | 2.28 | |
| Proteon Therapeutics | 0.0 | $75k | 188k | 0.40 |
